Extract notice to the Minister
Odensify (ostéoporose)
Common name / Subject : denosumab
Name of the manufacturer : Jamp
Form : Sol. Inj. S.C. (ser)
Dosage : 60 mg/ml (1 ml)
Name of the manufacturer : Jamp
Form : Sol. Inj. S.C. (ser)
Dosage : 60 mg/ml (1 ml)
Indication : Médicament biosimilaire: Ostéoporose
INESSS' Recommendation
Inscription – Sous conditions
Minister's decisions
À venir
Evaluation published on August 25, 2026
INESSSid: 29106
Recevable on February 09, 2026